Pangenomic Health Inc. (NARA.CN)
CAD 0.14
(0.0%)
CAD 0.14
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | - | - | - | - | - |
| Cost of Revenue | 681.43 Thousand | 11.11 Thousand | 2127.00 | - | - |
| Gross Profit | -681.43 Thousand | -11.11 Thousand | -2127.00 | - | - |
| Operating Expenses | 2.03 Million | 3.64 Million | 868.65 Thousand | 136.94 Thousand | 3438.00 |
| Selling, General and Administrative Expenses | 1.77 Million | 3.09 Million | 736.85 Thousand | 136.94 Thousand | 72.00 |
| Research and Development Expenses | 253.78 Thousand | 534.11 Thousand | 129.66 Thousand | - | - |
| Other Expenses | - | 11.11 Thousand | 2127.00 | - | - |
| Cost and Expenses | 2.71 Million | 3.64 Million | 868.65 Thousand | 136.94 Thousand | 3438.00 |
| Operating Income | -2.71 Million | -3.63 Million | -852.81 Thousand | -136.95 Thousand | -72.00 |
| Interest Expense | 44.03 Thousand | 1311.00 | 2466.00 | 3317.00 | - |
| Income Tax Expense | - | 8.35 Million | 2466.00 | -134.86 | -3.37 |
| Earnings before Tax | -2.97 Million | -11.99 Million | -2.64 Million | -139.98 Thousand | -3438.00 |
| Net Income | -2.97 Million | -20.34 Million | -2.65 Million | -139.98 Thousand | -3438.00 |
| Earnings Per Share Basic | -0.30 | -2.19 | -1.34 | -0.24 | -0.01 |
| Earnings Per Share Diluted | -0.30 | -2.19 | -1.34 | -0.24 | -0.01 |
| Weighted Average Shares Outstanding | 9.98 Million | 5.48 Million | 1.97 Million | 586 Thousand | 586 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 9.98 Million | 5.48 Million | 1.97 Million | 586.93 Thousand | 586.93 Thousand |
| Gross Margin | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - |
| Profit Margin | - | - | - | - | - |
| EBITDA | -2.71 Million | -3.56 Million | -847.5 Thousand | -1808.00 | -3366.00 |
| Earnings Before Tax Margin | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 3126.00 | 3127.00 | 3127.00 | 12.4 Thousand | 3127.00 | 3126.00 |
| Gross Profit | -3126.00 | -3127.00 | -3127.00 | -12.4 Thousand | -3127.00 | -3126.00 |
| Operating Expenses | 228.33 Thousand | 200.13 Thousand | 555.55 Thousand | 2.92 Million | 374.14 Thousand | 908.95 Thousand |
| Selling, General and Administrative Expenses | 218.96 Thousand | 224.34 Thousand | 487.62 Thousand | - | 350.14 Thousand | 800.61 Thousand |
| Research and Development Expenses | 9370.00 | -24.2 Thousand | 30.58 Thousand | - | -1648.00 | 64.86 Thousand |
| Other Expenses | 7578.00 | - | -37.35 Thousand | -37.35 Thousand | - | - |
| Cost and Expenses | 231.46 Thousand | 203.26 Thousand | 558.67 Thousand | 2.94 Million | 374.14 Thousand | 908.95 Thousand |
| Operating Income | -231.46 Thousand | -203.26 Thousand | -558.68 Thousand | -2.94 Million | -373.57 Thousand | -908.4 Thousand |
| Interest Expense | 13.41 Thousand | 19.78 Thousand | 19.38 Thousand | 44.03 Thousand | 12.15 Thousand | 9506.00 |
| Income Tax Expense | 4.00 | 3.00 | 3.00 | -2.00 | 12.15 Thousand | 9506.00 |
| Earnings before Tax | -2.54 Million | -218.74 Thousand | -552.87 Thousand | -2.97 Million | -400.38 Thousand | -961.44 Thousand |
| Net Income | -2.54 Million | -218.74 Thousand | -552.87 Thousand | -2.97 Million | -400.38 Thousand | -961.44 Thousand |
| Earnings Per Share Basic | -0.24 | -0.02 | -0.05 | - | -0.04 | -0.10 |
| Earnings Per Share Diluted | -0.24 | -0.02 | -0.05 | - | -0.04 | -0.10 |
| Weighted Average Shares Outstanding | 10.59 Million | 10.49 Million | 10.24 Million | 9.98 Million | 9.93 Million | 9.93 Million |
| Weighted Average Shares Outstanding (Diluted) | 10.59 Million | 10.49 Million | 10.24 Million | 9.98 Million | 9.93 Million | 9.93 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -228.33 Thousand | -200.13 Thousand | -555.55 Thousand | - | -370.45 Thousand | -905.28 Thousand |
| Earnings Before Tax Margin | - | - | - | - | - | - |
8305
3789
7715
600323
HCU
PGHN